Yaohai Bio-Pharma, founded in 2010, is a CDMO service provider focusing on microbial expression system, providing one-stop and end-to-end biopharmaceutical services for global customers. We focus on the fields of “recombinant protein/polypeptides, mRNA/plasmids, nanobodies, novel recombinant vaccines”, etc., and are committed to building an open, comprehensive and integrated production and research service platform for CRO/CDMO/MAH. The scope of business covers one-stop CMC services throughout the drug life cycle, such as engineering bacteria construction, strain bank establishment, lab scale process development and optimization, pilot process scale-up and production, clinical sample preparation, specification establishment, analytical method development and validation, compliant production (GMP), quality management system establishment, registration application, etc.

Adhering to the service concept of "Serve with heart, create the future together", we persevere in empowering the global new drugs development with the mission of "Establish global standards, boost new drug development process, and achieve healthy life".